Related references
Note: Only part of the references are listed.Arginine methylation of USP9X promotes its interaction with TDRD3 and its anti-apoptotic activities in breast cancer cells
Nithya Narayanan et al.
CELL DISCOVERY (2017)
Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier
Emma Bondy-Chorney et al.
PLOS GENETICS (2016)
Stress granules, P-bodies and cancer
Paul Anderson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Myc and cell cycle control
Gabriel Bretones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Arginine methyltransferases as novel therapeutic targets for breast cancer
Alan Morettin et al.
MUTAGENESIS (2015)
Head-to-head antisense transcription and R-loop formation promotes transcriptional activation
Raquel Boque-Sastre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Aven recognition of RNA G-quadruplexes regulates translation of the mixed lineage leukemia protooncogenes
Palaniraja Thandapani et al.
ELIFE (2015)
β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
Jinhua Xu et al.
PLOS ONE (2015)
Readers of histone methylarginine marks
Sitaram Gayatri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis
Lu Wang et al.
CANCER CELL (2014)
Arginine Methylation Facilitates the Recruitment of TOP3B to Chromatin to Prevent R Loop Accumulation
Yanzhong Yang et al.
MOLECULAR CELL (2014)
The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer
Hany Onsy Habashy et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
PELP1 oncogenic functions involve CARM1 regulation
Monica Mann et al.
CARCINOGENESIS (2013)
Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes
Hongxia Cheng et al.
DIAGNOSTIC PATHOLOGY (2013)
The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation
Rossella Luca et al.
EMBO MOLECULAR MEDICINE (2013)
A novel function for the survival motoneuron protein as a translational regulator
Gabriel Sanchez et al.
HUMAN MOLECULAR GENETICS (2013)
Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation
Dongyi Xu et al.
NATURE NEUROSCIENCE (2013)
Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders
Georg Stoll et al.
NATURE NEUROSCIENCE (2013)
Stress granules and cell signaling: more than just a passing phase?
Nancy Kedersha et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Protein arginine methyltransferases and cancer
Yanzhong Yang et al.
NATURE REVIEWS CANCER (2013)
Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells
R. Mitchell Baldwin et al.
CELL CYCLE (2012)
Recognition of asymmetrically dimethylated arginine by TDRD3
Tomas Sikorsky et al.
NUCLEIC ACIDS RESEARCH (2012)
Crystal Structure of TDRD3 and Methyl-Arginine Binding Characterization of TDRD3, SMN and SPF30
Ke Liu et al.
PLOS ONE (2012)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects
Lisa Hubers et al.
HUMAN MOLECULAR GENETICS (2011)
Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers
Masanori Yoshimatsu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Deciphering arginine methylation: Tudor tells the tale
Chen Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Clinical evaluation of PRMT1 gene expression in breast cancer
Konstantina Mathioudaki et al.
TUMOR BIOLOGY (2011)
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Andrey I. Khramtsov et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
SMG6 interacts with the exon junction complex via two conserved EJC-binding motifs (EBMs) required for nonsense-mediated mRNA decay
Isao Kashima et al.
GENES & DEVELOPMENT (2010)
TDRD3 Is an Effector Molecule for Arginine-Methylated Histone Marks
Yanzhong Yang et al.
MOLECULAR CELL (2010)
Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP
Bastian Linder et al.
HUMAN MOLECULAR GENETICS (2008)
TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules
Isabelle Goulet et al.
HUMAN MOLECULAR GENETICS (2008)
Regulation of estrogen rapid signaling through arginine methylation by PRMT1
Muriel Le Romancer et al.
MOLECULAR CELL (2008)
Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo
Jonghwan Kim et al.
PLOS ONE (2008)
Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization
Isabelle Goulet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene
Selma El Messaoudi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines
M Lombaerts et al.
BRITISH JOURNAL OF CANCER (2006)
Tudor domains bind symmetrical dimethylated arginines
J Côté et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The origin of vimentin expression in invasive breast cancer:: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?
E Korsching et al.
JOURNAL OF PATHOLOGY (2005)
Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
T Nagahata et al.
CANCER SCIENCE (2004)
Relevance of breast cancer cell lines as models for breast tumours: an update
M Lacroix et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)